Ask the Expert

Hodgkin Lymphoma: Your Questions Answered

How is the treatment landscape changing for Hodgkin lymphoma? Tune in for news on novel immunotherapies, minimizing toxicities and side effect management strategies from Dr. John Sweetenham.

John Sweetenham, MD, FRCPC, FACP, Andrew Schorr

Ask the Expert

Is There a Higher Chance of Relapse for Primary Refractory Hodgkin Lymphoma Patients?

What are the chances of relapse in Hodgkin lymphoma patients? Watch as Dr. John Burke explains unique disease characteristics of refractory and primary refractory Hodgkin lymphoma, prognosis and treatment response.

Beth Kart Probert, John Burke, MD

Latest News

Ask the Expert

How Are Young Adults with Hodgkin Lymphoma Impacted by Treatment?

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Ask the Expert

Patient Demographics for Hodgkin Lymphoma: Understanding Disease Development in Different Age Groups

Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Ask the Expert

Ask the Expert

Hodgkin Lymphoma: Your Questions Answered

John Sweetenham, MD, FRCPC, FACP, Andrew Schorr

Is There a Higher Chance of Relapse for Primary Refractory Hodgkin Lymphoma Patients?

Beth Kart Probert, John Burke, MD

Latest News

How Are Young Adults with Hodgkin Lymphoma Impacted by Treatment?

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Patient Demographics for Hodgkin Lymphoma: Understanding Disease Development in Different Age Groups

Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Ask the Expert: Hodgkin Lymphoma

Beth Kart Probert, John Burke, MD

Knowledge is power.

Subscribe to e-newsletter(s) to receive emerging research and community updates right to your inbox.

Don't miss a beat.

Cancer Types

Living Well

Navigating Cancer

Patient Power Community

Events

About Us